MCCARTHY GRENACHE INC
10QSB, 2000-12-20
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: FIXED INCOME SHARES, NSAR-B, EX-27, 2000-12-20
Next: METLIFE INC, 8-K, 2000-12-20



                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                      Washington, DC 20549

                           FORM 10-QSB
   QUARTERLY REPORT FOR SMALL BUSINESS ISSUERS SUBJECT TO THE
                 1934ACT REPORTING REQUIREMENTS

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
   EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2000
Commission File No. 000- 28095






                     MCCARTHY GRENACHE, INC.
     (Exact name of registrant as specified in its charter)







Nevada                                            88-0412635
(State of organization) (I.R.S. Employer Identification No.)

3651 Lindell Road, Suite A, Las Vegas, NV 89103
(Address of principal executive offices)

Registrant's telephone number, including area code (702) 873-7404

Check whether the issuer (1) filed all reports required to be
file by Section 13 or 15(d) of the Exchange Act during the past
12 months and (2) has been subject to such filing requirements
for the past 90 days.  No X

There are 5,122,000 shares of common stock outstanding as of June
30, 2000.



                 PART I - FINANCIAL INFORMATION

ITEM 1.   FINANCIAL STATEMENTS

The  Audited financial statements for the period ending September
30, 2000.

                  INDEPENDENT AUDITORS' REPORT

Board of Directors
McCarthy Grenache, Inc.
Las Vegas, Nevada

I  have audited the accompanying balance sheets of
McCarthy  Grenache,  Inc.,  (a  development  stage
company)  as of September 30, 2000, and  September
30,   1999,   and   the  related   statements   of
operations,   cash   flows,   and    changes    in
stockholders' equity for the period from  December
19,  1997,  (date of inception) to  September  30,
2000.  These statements are the responsibility  of
McCarthy   Grenache,   Inc.'s   management.     My
responsibility is to express an opinion  on  these
financial statements based on my audit.

I  conducted my audit in accordance with generally
accepted   auditing  standards.   Those  standards
require  that  I  plan and perform  the  audit  to
obtain  reasonable  assurance  about  whether  the
financial   statements  are   free   of   material
misstatement.  An audit includes examining,  on  a
best  basis,  evidence supporting the amounts  and
disclosures in the financial statements.  An audit
also  includes assessing the accounting principles
used and significant estimates made by management,
as   well  as  evaluating  the  overall  financial
statement presentation.  I believe that  my  audit
provides a reasonable basis for my opinion.

In   my   opinion,   the  accompanying   financial
statements   present  fairly,  in   all   material
respects,  the  financial  position  of   McCarthy
Grenache,  Inc.  as  of September  30,  2000,  and
September 30, 1999, and the results of operations,
cash  flows,  and changes in stockholders'  equity
for  the  periods  then  ended,  as  well  as  the
cumulative  period  from  December  19,  1997,  in
conformity   with  generally  accepted  accounting
principles.

     /s/ David Coffey,
     Certified Public Accountant
     December 7, 2000

     McCarthy Grenache, Inc.

                  (A Development Stage Company)
                          BALANCE SHEET
<TABLE>
<S>                                   <C>          <C>
                                       September    September
                                          30,          30,
                                         2000         1999

               ASSETS

Cash                                         815        20,065

Total Assets                                 815        20,065

    LIABILITIES AND STOCKHOLDERS'
               EQUITY
Accounts payable                           5,900           400

Total Liabilities                          5,900           400

Stockholders' Equity
Common stock, authorized 25,000,000
Shares at $.001 par value, issued and
Outstading 5,122,000 shares and
5,042,000 shares, respectively              5,122         5,122
Additional paid-in capital                 26,820        26,820
Deficit accumulated during the
Development stage                        (37,027)      (12,277)
TOTAL STOCKHOLDERS' EQUITY                (5,085)      (19,665)

TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY                         815        20,065
</TABLE>

 The accompanying notes are an integral part of these financial
                           statements.



                     McCarthy Grenache, Inc.
                  (A Development Stage Company)
               STATEMENT OF OPERATIONS AND DEFICIT
            ACCUMULATED DURING THE DEVELOPMENT STAGE
<TABLE>
<S>                              <C>          <C>           <C>
                                   Jan. 1,    Jan. 1, 1999       From
                                   2000 to    to September    Inception
                                  September     30, 1999    Dec. 19, 1997
                                  30, 2000                   to September
                                                               30, 2000
Income                                  -0-            -0-            -0-

Expenses
  Organization Expense                  -0-             -0-            400
  Rent                                  -0-             500          5,600
  Professional Fees                   5,000             -0-          4,250
  Loss on invesment in                  -0-             -0-          6,942
subsidiary
  Consulting                         18,000             -0-         18,000
  Fees and licenses                     500             -0-            500
  Office expenses                       -0-             852          1,335

  Total expenses                     23,500           1,352         37,027

Net loss                           (23,500)         (1,352)       (37,027)

Retained earnings,
Beginning of period                (13,527)        (10,925)

Deficit accumulated during
The development stage              (37,027)        (12,277)


Earnings (loss) per share
     Assuming dilution:
Net loss                               0.00            0.00         (0.01)

Weighted average shares
Outstanding                       5,122,000       5,050,888      5,069,059
</TABLE>

 The accompanying notes are an integral part of these financial
                           statements.


                     McCarthy Grenache, Inc.
                  (A Development Stage Company)
          STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
  FOR THE PERIOD FROM DECEMBER 19, 1997, (Date of Inception) TO
                          JUNE 30, 2000
<TABLE>
<S>                             <C>          <C>         <C>          <C>
                                                         Additional     Total
                                   Common       Stock      paid-in
                                   Shares      Amount      Capital

Balance, December 19, 1997              ---     $    ---   $     ---   $     ---

Issuance of common stock for
cash December 24, 1997               40,000           40       3,960       4,000

Exchange of stock (page 6, Note
D)
December 26, 1997                 4,942,000        4,942         -0-       4,942

Less net loss                           -0-          -0-         -0-     (4,942)

Balance, December 31, 1997        4,982,000        4,982       3,960       4,000

Issuance of common stock for
cash February, 1998                  60,000           60       5,940       6,000

Less offering costs                     -0-          -0-     (3,000)     (3,000)

Less net loss                           -0-          -0-         -0-     (5,983)

Balance, December 31, 1998        5,042,000        5,042       6,900       1,017

Issuance of common stock for
cash September 30, 1999              80,000           80      19,920      20,000

Less net loss                           -0-          -0-         -0-     (2,602)

Balance, December 31, 1999        5,122,000        5,122      26,820      18,415

Less net loss                           -0-          -0-         -0-    (23,500)

Balance, September 30, 2000       5,122,000     $  5,122   $  26,820  $  (5,085)
</TABLE>
 The accompanying notes are an integral part of these financial
                           statements.


                     McCarthy Grenache, Inc.
                  (A Development Stage Company)
                     STATEMENT OF CASH FLOWS
<TABLE>
<S>                               <C>          <C>          <C>
                                    Jan. 1,      Jan. 1,         From
                                    2000 to      1999 to      Inception,
                                   Sept. 30,    Sept. 30,   Dec. 19, 1997
                                      2000         1999      to Sept. 30,
                                                                 2000

CASH FLOWS PROVIDED BY OPERATING
ACTIVITIES
Net Loss                            (23,500)        (1,352)       (37,027)
Non-cash items included in net           -0-            -0-            -0-
loss
Adjustments to reconcile net
loss to cash used by
operating activity                     5,500            -0-          5,900
    Accounts payable

NET CASH PROVIDED BY
OPERATING ACTIVITIES                (18,000)        (1,352)       (31,127)

CASH FLOWS USED BY
INVESTING ACTIVITIES                     -0-            -0-            -0-

NET CASH USED BY
INVESTING ACTIVITIES                     -0-            -0-            -0-

CASH FLOWS FROM FINANCING
ACTIVITIES
  Sale of common stock                   -0-             80          5,122
  Paid-in capital                        -0-         19,920         29,820
  Less offering costs                    -0-            -0-        (3,000)

NET CASH PROVIDED BY
FINANCING ACTIVITIES                     -0-            -0-         31,942

NET INCREASE IN CASH                (18,000)         18,648     $      815

CASH AT BEGINNING OF PERIOD           18,815          1,417

CASH AT END OF PERIOD                    815         20,065
</TABLE>

 The accompanying notes are an integral part of these financial
                           statements.



McCarthy Grenache, Inc.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
SEPTEMBER 30, 2000 AND SEPTEMBER 30, 1999

NOTE A    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

          The  Company was incorporated on December 19,
          1997,  under the laws of the State of Nevada.
          The  business  purpose of the Company  is  to
          produce surgical instruments.

          The  Company  will adopt accounting  policies
          and  procedures  based  upon  the  nature  of
          future transactions.

NOTE B    OFFERING COSTS

          Offering costs are reported as a reduction in
          the  amount  of paid-in capital received  for
          sale of the shares.

NOTE C    EARNINGS (LOSS) PER SHARE

          Basic  EPS  is  determined using  net  income
          divided   by  the  weighted  average   shares
          outstanding  during the period.  Diluted  EPS
          is  computed  by dividing net income  by  the
          weighted average shares outstanding, assuming
          all  dilutive  potential common  shares  were
          issued.   Since  the Company  has  no  common
          shares that are ptentially issuable, such  as
          stock   options,  covertible  securities   or
          warrants, basic and diluted EPS are the same.

NOTE D    RELATED PARTY TRANSACTIONS - STOCK EXCHANGE

          In  December of 1997, the Company was  formed
          by  Gregorian Surgical Instruments, Inc. with
          McCarthy  Grenache, Inc.  as  a  wholly-owned
          subsidiary.  On December 26, 1997, the stock-
          holders  of  Gregorian Surgical  Instruments,
          Inc.  approved  an exchange  of  all  of  the
          outstanding   stock  in  Gregorian   Surgical
          Instruments,  Inc.  for an  equal  number  of
          shares  of  McCarthy Grenache, Inc.   At  the
          time  of  the  exhange there  were  4,942,000
          Gregorian  shares outstanding which  resulted
          in   the  issuance  of  4,942,000  shares  of
          McCarthy Grenache, Inc. common stock at a par
          value  of  $.001  per share for  a  total  of
          $4,942.   The  excess of par value  over  the
          value  of  assets acquired was $4,942.   This
          transaction  was accounted for as  a  reverse
          merger.

McCarthy Grenache, Inc.
(A Development Stage Company)
NOTES TO FINANCIAL STATEMENTS
SEPTEMBER 30, 2000 AND SEPTEMBER 30, 1999
(continued)

NOTE D    RELATED PARTY TRANSACTIONS - STOCK EXCHANGE
          (continued)

          Upon  the  completion of the stock  exchange,
          Gregorian Surgical Instruments, Inc. became a
          wholly-owned subsidiary of McCarthy Grenache,
          Inc.   The  Board of Directors  approved  the
          dissolution     of     Gregorian     Surgical
          Instruments, Inc. in December of 1997.

NOTE E    COMMON STOCK

          In  December of 1997, the Company sold 40,000
          shares of its common stock at $.10 per share,
          for  a total of $4,000.  In February of 1998,
          the Company sold another 60,000 shares of its
          common stock at $.10 per share for a total of
          $6,000.   Then  in  September  of  1999,  the
          Company  sold  80,000 shares  of  its  common
          stock  at  $.25  per share  for  a  total  of
          $20,000.   The proceeds were to be  used  for
          the development of a medical equipment supply
          business.

ITEM 2.   MANAGEMENT'S PLAN OF OPERATION

NOTE REGARDING PROJECTIONS AND FORWARD LOOKING STATEMENTS

This  statement  includes  projections  of  future  results   and
"forward-looking statements" as that term is defined  in  Section
27A  of  the  Securities Act of 1933 as amended (the  "Securities
Act"), and Section 21E of the Securities Exchange Act of 1934  as
amended (the "Exchange Act"). All statements that are included in
this  Registration Statement, other than statements of historical
fact,   are   forward-looking  statements.  Although   Management
believes that the expectations reflected in these forward-looking
statements  are  reasonable, it can give no assurance  that  such
expectations  will prove to have been correct. Important  factors
that  could  cause actual results to differ materially  from  the
expectations are disclosed in this Statement, including,  without
limitation,   those  expectations  reflected  in  forward-looking
statements contained in this Statement.

                        Plan of Operation

The  Company  is  engaged  in the development  of  a  principally
wholesale  medical supplies, surgical instruments, and  equipment
supply  service.  The  Company's products  are  intended  to  be:
bathroom  safety bars for the infirm, canes, colostomy  supplies,
crutches,  gloves,  stethoscopes,  nebulizers,  oxygen  supplies,
walkers,  wheel chairs, and wheelchair van modification kits  for
the disabled. The Company's products will be marketed to the aged
and  the  infirm. Management of the Company believes there  is  a
demand for these products due to the rapid increase in the age of
the  population in the US due to better medical care and the baby
boom  population  reaching  retirement  age.  Management  further
believes  that  the rapid expansion of the Las  Vegas  area  will
create a shortage of the types of products the Company intends to
market.

The Company intends to lease a suitable office/warehouse and will
wholesale  products  directly to retailers, medical  and  nursing
home   facilities   through  mail  order,  Internet   order   and
advertising  in  the press and various other media.  The  Company
anticipates  being  able  to  broker  orders  through   utilizing
attainable  contacts  within the medical  supplies  industry  and
matching  vendors  with  end-users via wholesaling.  The  Company
intends to generate revenue in the future by being listed in  the
yellow  pages and by developing its web-site for Internet  orders
and  inquiries.  At  this time, the Company  does  not  have  any
principal business suppliers.

The  Company  plans  to market and promote its wholesale  medical
supplies  starting  in  Nevada.  The  Company  has  reserved  the
Internet site "www.mccarthymedical.com" which is currently  under
development and is expected to be operational by March  15,  2000
or  shortly thereafter. Since public interest in health is at  an
all  time  high and growing, our presence on the Internet,  along
with increased information on the Internet, and the aging of  the
baby  boom  generation, should result in  the  development  of  a
vastly  improved  medical supply industry.  Many  items  such  as
wheelchairs,  walkers, and mobility equipment for  the  aged  and
infirm  are  automatically  approved by  most  medical  insurance
programs.  There  is a shortage of ambulatory  equipment  in  the
United States today due to the increasing age of the population.

                      Website and Ecommerce

The  Company is in the process of developing an Internet  Website
located  on  the  World Wide Web at www.mccarthymedical.com.  The
Website  is  in  the  process of being constructed.  The  Company
anticipates  that  the  Website, once  it  is  constructed,  will
promote the Company's medical supplies and equipment.

                            Marketing

The  Company  intends to acquire and market medical supplies  and
equipment  for  the  aged  direct  to  the  retailers  from   the
manufacturers.  The Company intends to rely on a  marketing  team
and  for  the prospects of e-commerce to implement the  Company's
marketing objectives. The Company also intends to utilize  direct
mailing, and e-mail to solicit manufacturers and retailers.

The   Company's  marketing  and  licensing  strategy  is  to  (i)
establish  and  expand the sales of the Company's products;  (ii)
selectively  establish licensed product lines to be marketed  and
promoted on the Company's offline developed website; (iii) expand
the  number  of representatives; and, (iv) acquire  or  establish
relationships  with  major manufacturers  businesses,  companies,
properties or technologies.

The  Company  will purchase most of its inventory  from  existing
manufacturers principally in North America and Asia. To date,  no
contracts  have been executed and the Company does not anticipate
entering into any contracts due to lack of funding. Upon funding,
letters of credit may be sought.

The Company does not anticipate being dependent on one major or a
few  major  customers. The Company intends  to  supply  to  large
nursing  facilities and hospitals as well as to major drug  store
chains  and emergency clinics. However, at this time, the Company
does  not  have any contracts with any such organizations.  Also,
management of the Company expects that the proliferation  of  web
pages  throughout  various search engines on  the  Internet  will
attract  customers.  However, there  is  no  guarantee  that  the
Company's  web-site, when completed, will have a positive  impact
on the Company's business.

                           Competition

The  Company's  competition  varies  among  its  business  lines.
Competition in these products and services is primarily  centered
on styling, quality, price, brand recognition and service with an
emphasis  on  the  latter.  In  order  for  the  Company  to   be
competitive  in these marketplaces, the Company must  effectively
maintain and promote the quality of its services and its products
among consumers and establish strong marketing relationships with
manufacturers  and  distributors of products which  enhance  that
quality  image. While the Company believes that it  will  compete
effectively,  the Company competes with a number of manufacturers
and  marketers  of  medical  supplies and  equipment  which  have
substantially  greater resources than the  Company  and  many  of
which  have well-recognized brand name contracts and broader  and
more  established distribution networks. The Company  anticipates
being  able to utilize its smaller size to attract those  seeking
more  personalized service and to maintain its ability  to  adapt
with   technological  changes  over  the  Internet  and  in   the
marketplace. Further, the Company expects to utilize the Internet
to  further  attract  customers via various search  engines  upon
completion of various web pages. Specific organizations with whom
the Company intends to compete are A to Z Medical Supply, Medical
Mart and Mobility Plus, all located in Las Vegas, Nevada.  As the
Company has not started marketing products, it presently  has  no
share of this market.

                            Employees

As  of  the date of this Registration Statement, the Company  has
two  part  time employees, neither of whom have entered  into  an
employment arrangement with the Company. The Company's president,
Sean  McCarthy, works full-time for the Company. The Company  has
no   collective  bargaining  agreements  covering  any   of   its
employees, has not experienced any material labor disruption  and
is unaware of any efforts or plans to organize its employees. The
Company considers relations with its employees to be good.

Other  than  the development of its website, the Company  has  no
intellectual property rights.

                   PART II - OTHER INFORMATION

ITEM 1.   LEGAL PROCEEDINGS

The  Company  is  not  a  party  to any  material  pending  legal
proceedings and, to the best of its knowledge, no such action has
been threatened by or against the Company.

ITEM 2.   CHANGES IN SECURITIES AND USE OF PROCEEDS

No issues of securities and no changes in the existing securities
took place during the period covered by this report.  At the  end
of the quarter there were 5,122,000 shares of common stock issued
and outstanding.

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No such matters were submitted during the most current quarter.

ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K

EXHIBITS

a)     The  exhibit  consisting  of  the  Company's  Articles  of
Incorporation is attached to the Company's Form 10-SB,  filed  on
February  29, 2000. This exhibit is incorporated by reference  to
that Form.

b)    The  exhibit consisting of the Company's Bylaws is attached
to  the  Company's Form 10-SB, filed on February 29,  2000.  This
exhibit is incorporated by reference to that Form.

Reports on Form 8-K:  None

27   Financial Data Schedule

                           SIGNATURES

Pursuant  to  the  requirements of Section 12 of  the  Securities
Exchange  Act  of  1934,  the Registrant  has  duly  caused  this
registration  statement  to  be  signed  on  its  behalf  by  the
undersigned, thereunto duly authorized.



                           McCarthy Grenache, Inc.



                           By: /s/ Sean McCarthy
                              Sean McCarthy, President and CEO



                           Date: December 20, 2000






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission